STING1 and neoplasm: The efficient intracellular delivery of STING@Mn greatly increased its antitumor efficacy, as evidenced by a more significant decrease in the tumor volume when nanoSTING@Mn was IT administered in comparison with STING@Mn (1.3‐fold; p = 0.047).